Frontiers | Mitochondrial inhibitors: a new horizon in breast cancer therapy
商品説明・詳細
送料・お届け
商品情報
Frontiers | Mitochondrial inhibitors: a new horizon in breast cancer therapy,Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype: Cell Reports,MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer,KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges | Molecular Cancer | Full Text,KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges | Molecular Cancer | Full Text